Kura Oncology, Inc.

符号: KURA

NASDAQ

20.59

USD

今天的市场价格

-10.6467
市盈率
-0.2997
PEG比率
1.57B
MRK市值
0.00%
DIV收益率

Kura Oncology, Inc. (KURA) 财务报表

Q: 什么是 Kura Oncology, Inc. (KURA) 总资产是多少？

Kura Oncology, Inc. (KURA) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 Kura Oncology, Inc. (KURA). 的默认数据。公司收入显示 0 M 的平均值，即 0.000 % 增长率。整个期间的平均毛利润为 -0.156 M，即 -0.094 %. 平均毛利率为 0.000 %. 公司去年的净收入增长率为 0.122 %，等于 -8.281 % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 Kura Oncology, Inc. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 -0.016. 在流动资产领域，KURA 的报告货币为432.481. 这些资产中的很大一部分，即 423.957 是现金和短期投资。与去年的数据相比，该部分的变化率为-0.032%. 公司的长期投资虽然不是其重点，但以报告货币计算的0.2（如果有的话）为0.2。这表明与上一报告期相比，-4.762% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 9.332. 这一数字表明，0.226% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 397.273. 这方面的年同比变化率为 -1.698%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为2.8，存货估值为 0，商誉估值为 0（如有. 无形资产总额（如果有）按 0 估值.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008
balance-sheet.row.cash-and-short-term-investments	1880.65	424	438	518	633.3	236.9	179	93.1	67.8	85.7	1.1	0	0	0	0	0	0
balance-sheet.row.short-term-investments	1723.96	386.6	386.2	427.3	307.8	210.8	162.9	81.7	58.1	70.3	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	2.8	2.8	0	0	0	0	0.2	0.2	0.3	0.4	0	0	0	0	0	0	0
balance-sheet.row.inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-current-assets	32.43	5.7	8.4	4.3	4	2.7	2	1.3	0.7	0.7	0	0	0	0	0	0	0
balance-sheet.row.total-current-assets	1907.21	432.5	446.4	522.3	637.3	239.6	181.2	94.6	68.8	86.9	1.2	0	0	0	0	0	0
balance-sheet.row.property-plant-equipment-net	31.78	8.9	6.4	8.2	8.4	0	0	0	0	0.1	0	0	0	0	0	0	0
balance-sheet.row.goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-investments	0.61	0.2	0.2	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	23.08	7.4	3.3	3.3	1.4	2.3	1.2	1.2	1	0.3	0.2	0	0	0	0	0	0
balance-sheet.row.total-non-current-assets	55.47	16.5	9.9	11.8	9.9	2.4	1.2	1.2	1	0.4	0.2	0	0	0	0	0	0
balance-sheet.row.other-assets	8.67	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	1971.35	448.9	456.3	534.1	647.2	242	182.4	95.9	69.8	87.3	1.4	0	0	0	0	0	0
balance-sheet.row.account-payables	6.4	2.3	1.5	3.2	2.8	3.5	4.1	1.5	1.4	1.8	0.4	0	0	0	0	0	0
balance-sheet.row.short-term-debt	6.9	1.5	2.3	2.3	5.1	0.3	0	1.5	0	0	2	0.1	0.1	0.1	0.1	0	0
balance-sheet.row.tax-payables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-debt-total	51.38	9.3	11.7	4.6	9.9	7.3	7.5	5.6	7.3	0	0.5	0.1	0.1	0.1	0	0	0
Deferred Revenue Non Current	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	109.76	31.5	20.2	17	18.2	11.8	9.5	7	4	3.2	0.6	0	0	0	0	0	0
balance-sheet.row.total-non-current-liabilities	60.43	16.4	12	5	10.3	7.6	7.8	6	7.5	0.1	1.8	0.1	0.1	0.1	0	0	0
balance-sheet.row.other-liabilities	-23.9	0	0	0	0	0	0	0	0	0	0	-0.1	-0.1	-0.1	0	0	0
balance-sheet.row.capital-lease-obligations	25.89	6.4	4.9	6.9	7.7	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	155.48	51.7	36	27.4	36.3	23.2	21.4	16	12.9	5.2	4.8	0.1	0.1	0.1	0.1	0	0
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	0.03	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0
balance-sheet.row.retained-earnings	-2811.11	-721.4	-568.8	-433	-302.5	-212.9	-149.7	-89.3	-53.9	-26.3	-3.7	-0.2	-0.1	-0.1	-0.1	-0.1	0
balance-sheet.row.accumulated-other-comprehensive-income-loss	-10.84	-1.3	-8	-1.8	0	0.3	-0.1	0	0	-0.1	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	3514.16	1120	8	1.8	-0.1	-0.3	0.1	169.2	110.7	108.5	0.2	0	0	0	0	0	0
balance-sheet.row.total-stockholders-equity	692.24	397.3	-568.8	-433	-302.5	-212.9	-149.7	79.9	56.9	82.1	-3.4	-0.1	-0.1	-0.1	0	0	0
balance-sheet.row.total-liabilities-and-stockholders-equity	871.62	448.9	-532.8	-405.5	-266.2	-189.7	-128.3	95.9	69.8	87.3	1.4	0	0	0	0	0	0
balance-sheet.row.minority-interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	692.24	397.3	-568.8	-433	-302.5	-212.9	-149.7	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	871.62	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	1724.16	386.8	386.2	427.3	307.8	210.8	162.9	81.7	58.1	70.3	0	0	0	0	0	0	0
balance-sheet.row.total-debt	64.64	17.2	14	6.9	15	7.5	7.5	7.1	7.3	0	2.5	0.2	0.2	0.1	0.1	0	0
balance-sheet.row.net-debt	-92.05	-20.1	-37.8	-83.8	-310.5	-18.6	-8.6	-4.3	-2.4	-15.4	1.4	0.2	0.2	0.1	0	0	0

现金流量表

在 Kura Oncology, Inc. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 -0.129 的转变。该公司最近通过发行 94.78 扩大了股本，与上一年相比出现了0.000 的差异. 有趣的是，公司的部分股票，特别是 0，是由公司自己回购的。这一举动导致0.000 比上一年有所变化。同时，以报告货币计算，公司的应付账款目前为 10.33. 公司的投资活动产生了现金使用净额，按报告货币计算达到15557000.000. 与上一年相比， -0.523 发生了变化. 在同一时期，公司记录了 0.85, 15.56 和 0，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将0 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 94.78，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008
cash-flows.row.net-income	-168.09	-152.6	-135.8	-130.5	-89.6	-63.1	-60.4	-35.4	-27.6	-22.6	-3.7	0
cash-flows.row.depreciation-and-amortization	-2.39	0.8	0.8	0.6	0.2	0	0	0	0	0	0	0
cash-flows.row.deferred-income-tax	0	-19.5	0	4.6	0	0	-1.4	-0.3	0.1	0.4	0	0
cash-flows.row.stock-based-compensation	21.24	28.1	26.3	23.6	12.8	9.4	8.7	4.5	2.1	2.3	0	0
cash-flows.row.change-in-working-capital	15.09	7.8	-3	-3.2	6.4	0.1	4.4	2.6	-0.1	1.4	-1.7	-0.1
cash-flows.row.account-receivables	0	0	0	0	0	0.2	0	0.1	0.1	-0.4	0	0
cash-flows.row.inventory	0	0	0	0	0	-0.9	-0.4	-0.8	-0.2	0.2	0	0
cash-flows.row.account-payables	12.56	10.3	-0.8	-2.5	5.7	0.9	5.1	3.6	0.5	2.8	0	0
cash-flows.row.other-working-capital	-0.6	-2.5	-2.2	-0.7	0.7	-0.1	-0.3	-0.4	-0.5	-1.2	-1.7	0
cash-flows.row.other-non-cash-items	-7.37	10.5	1.7	0.4	0.4	-1.1	0.2	0.1	0	0.6	4.5	0.1
cash-flows.row.net-cash-provided-by-operating-activities	-137.8	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-0.22	-0.2	-0.6	-1.1	-2.2	0	0	0	0	-0.1	0	0
cash-flows.row.acquisitions-net	0.01	-15.6	0	0.1	0.1	0	0	0	0	0	0	0
cash-flows.row.purchases-of-investments	-531.05	-409.8	-270.7	-445.7	-321	-227.6	-237.4	-100.6	-56.4	-76.6	0	0
cash-flows.row.sales-maturities-of-investments	440.36	425.5	303.9	320	223.2	181.2	158.1	77.2	68.6	6	0	0
cash-flows.row.other-investing-activites	-0.01	15.6	0	-0.1	-0.1	0	0	0	0	0	0	0
cash-flows.row.net-cash-used-for-investing-activites	-90.91	15.6	32.6	-126.8	-99.9	-46.3	-79.3	-23.4	12.2	-70.6	0	0
cash-flows.row.debt-repayment	0	0	-9.4	-7.3	-0.3	0	-1.3	-0.3	0	0	0	0
cash-flows.row.common-stock-issued	240.6	94.8	24.7	4.4	459.3	108.2	132.2	53.7	0	97.9	0	0
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-financing-activites	97.43	94.8	23.3	-0.6	10.2	2.9	1.7	0.2	7.5	5	2	0
cash-flows.row.net-cash-used-provided-by-financing-activities	243.15	94.8	38.6	-3.4	469.3	111.1	132.6	53.6	7.5	102.9	2	0
cash-flows.row.effect-of-forex-changes-on-cash	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	14.24	-14.5	-38.9	-234.8	299.6	10	4.7	1.7	-5.7	14.3	1.1	0
cash-flows.row.cash-at-end-of-period	156.9	37.3	52	90.9	325.7	26.1	16.1	11.4	9.7	15.4	1.1	0
cash-flows.row.cash-at-beginning-of-period	142.66	51.8	90.9	325.7	26.1	16.1	11.4	9.7	15.4	1.1	0	0
cash-flows.row.operating-cash-flow	-137.8	-124.8	-110.1	-104.6	-69.8	-54.8	-48.7	-28.4	-25.3	-17.9	-0.8	0
cash-flows.row.capital-expenditure	-0.22	-0.2	-0.6	-1.1	-2.2	0	0	0	0	-0.1	0	0
cash-flows.row.free-cash-flow	-138.01	-125	-110.7	-105.7	-72	-54.8	-48.7	-28.4	-25.3	-18	-0.8	0

利润表行

Kura Oncology, Inc. 的收入与上期相比变化了 0.000%。据报告, KURA 的毛利润为 -0.85。该公司的营业费用为 164.96，与上年相比变化了 17.939%. 折旧和摊销费用为 0.85，与上一会计期间相比变化了 0.119%. 营业费用报告为 164.96，显示17.939% 的同比变化。销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。基于近期数据的EBITDA为 0，同比增长-0.179%. 营业收入为 -165.8，与上年相比变化了0.179%. 净利润的变化率为 0.122%。去年的净收入为-152.63.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008
income-statement-row.row.total-revenue	1.27	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.cost-of-revenue	0.64	0.8	0.8	0.6	0.2	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.gross-profit	0.63	-0.8	-0.8	-0.6	-0.2	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	126.31	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	57.38	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-0.21	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-2.5	0	4	0.8	2.3	4.3	2.4	0.6	0.8	1.2	2	0	0	0	0	0	0
income-statement-row.row.operating-expenses	183.48	165	139.9	131.3	91.9	67.5	62.9	36.1	28.4	23.9	3.9	0	0	0	0	0	0
income-statement-row.row.cost-and-expenses	183.69	165.8	139.9	131.3	91.9	67.5	62.9	36.1	28.4	23.9	3.9	0	0	0	0	0	0
income-statement-row.row.interest-income	11.86	14.7	4.3	1.2	2.8	4.7	3.2	0.8	0.5	0.1	0	0	0	0	0	0	0
income-statement-row.row.interest-expense	0.01	1.5	0.2	0.4	0.6	0.6	1	0.9	0.6	0.1	0	0	0	0	0	0	0
income-statement-row.row.selling-and-marketing-expenses	-0.21	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	10.68	13.2	4.8	1.4	2.5	4.3	2.4	0.6	0.8	1.2	0.3	0	0	0	0	0	0
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-2.5	0	4	0.8	2.3	4.3	2.4	0.6	0.8	1.2	2	0	0	0	0	0	0
income-statement-row.row.total-operating-expenses	10.68	13.2	4.8	1.4	2.5	4.3	2.4	0.6	0.8	1.2	0.3	0	0	0	0	0	0
income-statement-row.row.interest-expense	0.01	1.5	0.2	0.4	0.6	0.6	1	0.9	0.6	0.1	0	0	0	0	0	0	0
income-statement-row.row.depreciation-and-amortization	0.64	0.8	0.8	0.6	0.2	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.ebitda-caps	-174.06	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-174.89	-165.8	-140.6	-131.8	-92.1	-67.5	-62.9	-36.1	-28.4	-23.9	-3.9	0	0	0	0	0	0
income-statement-row.row.income-before-tax	-168.09	-152.6	-135.8	-130.5	-89.6	-63.1	-60.4	-35.4	-27.6	-22.6	-3.7	0	0	0	0	0	0
income-statement-row.row.income-tax-expense	3.07	0	0.2	-0.6	-0.2	0	3.4	0	0	0	0.3	0	0	0	0	0	0
income-statement-row.row.net-income	-168.09	-152.6	-136.1	-129.9	-89.4	-63.1	-60.4	-35.4	-27.6	-22.6	-3.7	0	0	0	0	0	0